Search

Search Constraints

You searched for: Author/Creator Wahl, Simone

Search Results

1. DNA-Methylation and Body Composition in Preschool Children: Epigenome-Wide-Analysis in the European Childhood Obesity Project (CHOP)-Study. Issue 1 (December 2017)

2. Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease: A Longitudinal Study of 11 461 Participants From Population-Based Cohorts. Issue 8 (20th August 2019)

3. [O1–05–05]: AMYLOID‐PET CONCORDANCE OF ELECSYS® CSF BIOMARKER IMMUNOASSAYS FOR ALZHEIMER's DISEASE. (1st July 2017)

4. P2‐231: EXPLORING THE NEED FOR ROBUST BIOMARKER ASSAYS IN ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES. (1st July 2019)

5. P3‐239: OPTIMIZED PATHWAYS FOR EARLY DETECTION OF ALZHEIMER'S DISEASE WITH BLOOD‐BASED BIOMARKERS. (1st July 2019)

6. [P4–155]: DERIVING A CUT‐OFF FOR THE ELECSYS® β‐AMYLOID (1–42) IMMUNOASSAY FOR USE IN CLINICAL TRIALS SUPPORTED BY ELI LILLY FOR PATIENTS WITH CLINICALLY DEFINED ALZHEIMER's DISEASE (AD). (1st July 2017)

7. Derivation of cutoffs for the Elecsys® amyloid β (1–42) assay in Alzheimer's disease. Issue 1 (10th August 2018)

8. Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project. Issue 1 (11th September 2018)

9. Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Issue 11 (1st March 2018)

10. O2‐09‐02: A UNIFIED PRE‐ANALYTICAL PROTOCOL FOR HANDLING OF CSF SAMPLES BEFORE ANALYSES OF AD BIOMARKER LEVELS. (1st July 2006)